Prescient Therapeutics logo

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular & targeted therapies.

14 employees · est. 2014 · Australia

VS
RiMO Therapeutics logo

RiMO Therapeutics

Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce toxicity.

est. 2015

Prescient Therapeutics is the older company (2014 vs 2015).

Side-by-Side Comparison

Prescient Therapeutics RiMO Therapeutics
Founded
2014 older 2015
Headquarters
Australia Not tracked yet
Employees
14 Not tracked yet
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health and Wellness
Funding Stage
Post Ipo Equity Grant
Total Funding
$3.00M $250.00K
Funding Rounds
1 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Oncology, Personalized Medicine, Cell Therapies, Targeted Therapies, Immunotherapy, Cancer Treatment, Clinical Stage Biotech, CAR-T Therapies, Solid Tumors, Hematological Cancers, Cellular Therapies, Clinical Trials, Biopharmaceuticals, Drug Development, Cancer Research Oncology Drug Development, Cancer Treatment, Radiotherapy, Radiodynamic Therapy, Tumor Eradication, Non-toxic Therapies, Combination Therapies, Unmet Medical Needs, Patient Care Improvement, Checkpoint Blockade Inhibitors, Immunotherapy, University Of Chicago Research, Innovative Therapy, Toxicity Reduction, Therapeutic Modalities
Website
ptxtherapeutics.com rimorx.com
Prescient Therapeutics logo

About Prescient Therapeutics

Prescient Therapeutics is a clinical stage oncology company with a focus on developing personalized medicine approaches for cancer treatment. The company is involved in the development of both targeted and cellular therapies. One of their prominent technologies is OmniCAR, a universal immune recept...

RiMO Therapeutics logo

About RiMO Therapeutics

RiMO Therapeutics, Inc. (RiMO) is a biotechnology startup established in 2015 with a mission to revolutionize cancer treatment. The company's proprietary Radio-immuno Metal-Organic (RiMO) technology, developed at the University of Chicago, aims to improve patient outcomes and reduce toxicity in canc...

We will tell you when either one moves

BounceWatch watches Prescient Therapeutics and RiMO Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Prescient Therapeutics and RiMO Therapeutics — by email.

Frequently Asked Questions

Prescient Therapeutics — A clinical stage oncology company developing personalised medicine approaches to cancer; cellular & targeted therapies.. RiMO Therapeutics — Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce toxicity.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Prescient Therapeutics has raised $3.00M while RiMO Therapeutics has raised $250.00K.
Prescient Therapeutics and RiMO Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Prescient Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Prescient Therapeutics on 6 Dec 2024, and RiMO Therapeutics on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes